What is the appropriate treatment for sodium azide poisoning?

Sodium Azide Poisoning Treatment

Treat sodium azide poisoning immediately with aggressive supportive care, consider hydroxocobalamin as the most rational antidote based on mechanistic similarities to cyanide poisoning, and implement early high-volume continuous veno-venous hemofiltration (HV-CVVH) with levocarnitine for severe cases.

Critical Initial Management

Sodium azide is a highly toxic chemical that inhibits cellular respiration similarly to cyanide, causing rapid cardiovascular collapse, profound hypotension, metabolic acidosis with elevated lactate, seizures, and death 1. Time is critical—patients can deteriorate from stable to fatal within hours.

Immediate Decontamination (if presenting early)

• Gastric lavage within 2 hours of ingestion if the patient presents early and can be safely performed 2
• Activated charcoal may be considered for recent ingestions 1
• Early decontamination can prevent development of acute poisoning 2

Antidote Selection

Hydroxocobalamin: First-Line Rational Choice

Hydroxocobalamin is the most mechanistically sound antidote for sodium azide poisoning based on the compound's similar mechanism to cyanide (both inhibit cytochrome oxidase) 1. While no formal antidote exists specifically for azide, the 2023 AHA guidelines recommend hydroxocobalamin as the preferred treatment for cyanide poisoning because it does not cause hypotension or exacerbate oxygen-carrying capacity concerns 3.

Key advantages of hydroxocobalamin:

• Does not worsen hypotension (critical since profound hypotension is the hallmark of azide toxicity)
• No risk of methemoglobinemia
• Can be given immediately without waiting for confirmatory testing 3

Alternative: Sodium Nitrite + Sodium Thiosulfate

If hydroxocobalamin is unavailable, the cyanide antidote kit (sodium nitrite followed by sodium thiosulfate) has been used in severe azide poisoning cases 1, 4. However, this carries significant risk:

• Sodium nitrite causes methemoglobinemia, reducing oxygen-carrying capacity
• Can worsen hypotension in already hemodynamically unstable patients
• Requires precise dosing in children and anemic patients 3

The evidence from case reports shows variable outcomes with this approach 4, with one fatal case despite treatment and one survival.

Hemodynamic Support

Aggressive Vasopressor Therapy

Profound refractory hypotension is the primary cause of death in sodium azide poisoning 5, 1. Expect to need:

• Multiple vasopressors simultaneously
• Potentially intra-aortic balloon pump for refractory shock 1
• Early consideration of mechanical circulatory support

Critical pitfall: Two recent fatal cases demonstrated that delayed intervention led to recurrent cardiac arrest despite initial stabilization 5. Once shock develops, it can become rapidly refractory to all interventions.

Enhanced Elimination Strategies

High-Volume CVVH + Levocarnitine: Emerging Evidence

The most promising recent development is the combination of HV-CVVH with levocarnitine 6. A 2025 case report demonstrated successful treatment of a supralethal dose using:

• High-volume continuous veno-venous hemofiltration
• Levocarnitine administration (substantially reduced lactate concentration)
• Comprehensive monitoring showing effective elimination of sodium azide in ultrafiltrate and urine

This represents the first documented survival from a supralethal dose and should be considered for severe poisonings.

Timing is Everything: The Fatal Flaw of Delayed Dialysis

Two 2025 fatal cases highlight that delayed enhanced elimination is ineffective 5:

• First patient: Hemodialysis started 13 hours post-ingestion—initially stabilized but developed recurrent arrest
• Second patient: Plasma exchange performed after presentation—temporary improvement followed by fatal recrudescence

The lesson: If you're going to use enhanced elimination, start immediately. Waiting until the patient is already in shock appears to be too late 5.

Hemodialysis vs. CVVH

While standard hemodialysis has been attempted 5, 1, HV-CVVH appears superior based on:

• Continuous removal vs. intermittent
• Better hemodynamic tolerance in shock states
• Documented efficacy in the only supralethal dose survival 6

Supportive Care Specifics

Metabolic Monitoring

• Lactate levels: Primary marker of toxicity and response to treatment 6, 4
• Potassium: Can be decreased 4
• Liver enzymes: Expect elevation (ALT, AST) 2, 4
• TSH: May be elevated 2

Cardiac Monitoring

• Dysrhythmias are common: Alternating tachycardia/bradycardia, supraventricular and ventricular extrasystoles 4
• ECG changes: ST segment abnormalities, negative T waves (especially leads III, V4-V6) 2, 4
• Cardiac arrest can occur suddenly, even after apparent stabilization 5, 4

Treatment Algorithm by Severity

Mild Exposure (<500 mg, early presentation, minimal symptoms)

1. Gastric lavage if within 2 hours
2. Activated charcoal
3. Supportive care with close monitoring for 24-48 hours
4. Serial lactate measurements

Moderate Exposure (500 mg-2 g, or symptomatic)

1. Immediate gastric lavage if feasible
2. Hydroxocobalamin administration (5 g IV over 15 minutes, can repeat)
3. Aggressive hemodynamic support as needed
4. Consider early HV-CVVH if lactate rising or hemodynamic instability
5. Levocarnitine supplementation
6. ICU monitoring minimum 72 hours

Severe Exposure (>2 g, shock, or cardiac arrest)

1. Immediate hydroxocobalamin (do not wait)
2. Immediate initiation of HV-CVVH + levocarnitine 6
3. Aggressive multi-vasopressor support
4. Prepare for mechanical circulatory support (ECMO, intra-aortic balloon pump)
5. Continuous cardiac monitoring for dysrhythmias

Critical Pitfalls to Avoid

1. Delayed treatment: Patients can appear stable initially then rapidly decompensate 5, 2
2. Waiting for confirmatory testing: Treat empirically based on history—no time for lab confirmation
3. Using sodium nitrite in hypotensive patients: Worsens the primary problem
4. Delayed enhanced elimination: If considering dialysis/CVVH, start immediately, not after shock develops 5
5. Premature discharge: Observe minimum 48-72 hours even if initially stable—second doses or delayed toxicity can be fatal 7
6. Secondary exposure: Medical personnel can be exposed—use appropriate PPE 1

Consultation

Immediately contact a medical toxicologist or regional poison center 3. Sodium azide poisoning is rare (averaging 7.8 cases/year globally) 1, and most clinicians will never see a case. Expert guidance is essential for optimizing the treatment approach.